Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Untangling tau-related dementia.

P Heutink1

  • 1Department of Clinical Genetics, Erasmus University, Rotterdam, The Netherlands. heutink@kgen.fgg.eur.nl

Human Molecular Genetics
|April 18, 2000
PubMed
Summary

Protein tau aggregates in the cytoplasm are hallmarks of neurodegenerative diseases like Alzheimer's. Mutations in the tau gene confirm its crucial role in neurodegeneration, paving the way for new dementia therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease.

Neurobiology of aging·2016
Same author

Determining the genome-wide kinship coefficient seems unhelpful in distinguishing consanguineous couples with a high versus low risk for adverse reproductive outcome.

BMC medical genetics·2015
Same author

A common polymorphism in the ABCB1 gene is associated with side effects of PGP-dependent antidepressants in a large naturalistic Dutch cohort.

The pharmacogenomics journal·2015
Same author

Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locus.

Molecular psychiatry·2015
Same author

Mutation frequency of PRKAR1B and the major familial dementia genes in a Dutch early onset dementia cohort.

Journal of neurology·2014
Same author

Exome sequencing is a useful diagnostic tool for complicated forms of hereditary spastic paraplegia.

Clinical genetics·2013

Area of Science:

  • Neuroscience
  • Pathology
  • Genetics

Background:

  • Cytoplasmic inclusions of aggregated, hyperphosphorylated protein tau are a key pathological feature in neurodegenerative disorders.
  • These disorders include Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration, and progressive supranuclear palsy.

Purpose of the Study:

  • To highlight the critical role of tau protein in neurodegeneration.
  • To discuss the implications of tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).
  • To underscore the progress in understanding tau-related neurodegenerative mechanisms.

Main Methods:

  • Review of pathological observations in neurodegenerative diseases.
  • Analysis of genetic findings related to tau mutations, specifically FTDP-17.
  • Synthesis of current understanding of neurodegeneration mechanisms driven by tau.

Main Results:

  • Mutations in the tau gene are definitively linked to FTDP-17, confirming tau's central role in neurodegeneration.
  • Significant advancements have been made in elucidating the mechanisms by which these tau mutations induce neurodegeneration.

Conclusions:

  • Tau protein aggregation and its genetic underpinnings are central to the pathogenesis of several dementia types.
  • Understanding these tau-related disease processes is vital for developing effective therapeutic strategies for dementia.

Related Experiment Videos